本頁面由Tiger Trade Technology Pte. Ltd.提供服務

4D Molecular Therapeutics

9.33
-0.8500-8.35%
盤後9.330.00000.00%19:49 EDT
成交量:105.97萬
成交額:1,018.92萬
市值:4.76億
市盈率:-3.86
高:10.33
開:10.00
低:9.32
收:10.18
52周最高:12.34
52周最低:2.24
股本:5,100.79萬
流通股本:3,678.36萬
量比:0.89
換手率:2.88%
股息:- -
股息率:- -
每股收益(TTM):-2.4186
每股收益(LYR):-2.4200
淨資產收益率:-27.57%
總資產收益率:-17.34%
市淨率:0.94
市盈率(LYR):-3.86

資料載入中...

2024/07/23

重要事件披露

Form 8-K - Current report
2024/07/17

重要事件披露

Form 8-K - Current report
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

重要事件披露

Form 8-K - Current report
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities